Share to
Overview
Specs
Technical Documents
Related
Articles
reviews
Consult
returns
Product introduction
PGMI-004A is a potent phosphoglycerate mutase 1 ( PGAM1 ) inhibitor with an IC 50 of 13.1 μM. In Vitro PGMI-004A inhibits PGAM1 with an IC 50 of approximately 13.1 μM and the K d value of the PGMI-004A-PGAM1 interaction is determined to be 7.2±0.7 μM from fluorescence-based binding assay. PGMI-004A may allosterically modulate the enzyme activity of PGAM1. The K i value is determined to be 3.91±2.50 μM using Dixon plot analysis. The K d value for protein-ligand interaction is calculated to be 9.4±2.0 μM. Inhibition of PGAM1 activity by PGMI-004A (20 μM) treatment results in decreased 2-PG and increased 3-PG levels in H1299 cells, which could be rescued by treatment with methyl-2-PG. Treatment with PGMI-004A (20 μM) results in significantly reduced lactate production that is rescued by methyl-2-PG treatment, but has no significant effect on intracellular ATP levels. PGMI-004A (20 μM) treatment results in decreased oxidative PPP flux and NADPH/NADP+ratio, as well as reduced biosynthesis of lipids and RNA, and cell proliferation in H1299 cells. PGMI-004A treatment results in decreased cell proliferation of diverse human cancer and leukemia cells, but not control human dermal fibroblasts (HDF), human foreskin fibroblasts (HFF), human HaCaT keratinocyte cells and human melanocyte PIG1 cells, suggesting minimal non-specific toxicity of PGMI-004A in normal, proliferating human cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo The xenograft experiment is performed by injecting H1299 cells to nude mice. Six days post-injection, mice are divided into two groups (n=8/group) and treated with either PGMI-004A (100mg/kg/day) or vehicle for 21 days. PGMI-004A treatment results in significantly decreased tumor growth and tumor size in treated mice compared with mice receiving vehicle control. Moreover, treatment with PGMI-004A effectively inhibits PGAM1 enzyme activity in tumors in vivo in resected tumors from xenograft nude mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:IC50: 13.1 μM (PGAM1)
Chinese name
PGMI-004A
English name
PGMI-004A
Chinese alias
-
English alias
-
CAS number
1313738-90-7
molecular formula
C21H12F3NO6S
molecular weight
463.38 g/mol
Exact mass
≥99%
PSA
129.000 Ų
Logp
4.700
Technical Documents
「No technical documents」
Related
「No upstream and downstream information yet」
Articles
「No related articles yet」
user reviews
Loading...
Consultation

Warm reminder:

Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.!

After Sales Services

Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.

Service Hotline:400-6226-992 ,We will handle it for you as soon as possible, thank you for your support and trust.!

PGMI-004A 5mg

PGMI-004A 5mg; supplied for laboratory research, analysis, inspection, and scientific procurement use; specifications: 5mg; ≥99%.

item number:P650879-5mg
Product model:5mg
level: 5mg; ≥99%
Lead Time:30days
sold 930 Items
Ask Solution engineer
Specifications:

5mg

Qty

Recommended for you